Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07573202 · ClinicalTrials.gov registry record · NA
Evaluation of Hypersensitivity Reactions to Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh in Shoulder Surgery
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT07573202 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 350 participants.
The verdict
NCT07573202, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of this study is to document the incidence of allergic contact dermatitis (ACD) to silk fibroin and 2-octyl cyanoacrylate mesh dressings after open shoulder surgery, to identify differences in clinic utilization for complications related to silk fibroin and 2-octyl cyanoacrylate mesh dressings and to collect patient reported outcome measures (PROMs) related to patient comfort and satisfaction for silk fibroin and 2-octyl cyanoacrylate mesh dressings.
Interventions
- DEVICE Silk fibroin (SYLKE)
- DEVICE 2-octyl cyanoacrylate mesh (Dermabond PRINEO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2028-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07573202
The ClinicalTrials.gov registry entry for NCT07573202 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Silk fibroin (SYLKE) is the first listed.
NCT07573202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07573202 about?
NCT07573202 is a clinical study titled "Evaluation of Hypersensitivity Reactions to Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh in Shoulder Surgery". The purpose of this study is to document the incidence of allergic contact dermatitis (ACD) to silk fibroin and 2-octyl cyanoacrylate mesh dressings after open shoulder surgery, to identify differences in clinic utilization for complications related to silk fibroin and 2-octyl cyanoacrylate mesh dre...
What is the current status of trial NCT07573202?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2026-06-30. Estimated completion is 2028-07-30.
What interventions are being tested in trial NCT07573202?
The interventions under investigation include: Silk fibroin (SYLKE) (DEVICE), 2-octyl cyanoacrylate mesh (Dermabond PRINEO) (DEVICE).
Who is sponsoring clinical trial NCT07573202?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.